Titre:
  • Present and future breast cancer management-bench to bedside and back: A positioning paper of academia, regulatory authorities and pharmaceutical industry
Auteur:Bartsch, Rupert; Berghoff, Anna Sophie; Zielinski, Christoph; Gnant, Michael; Frings, Stefan; Marty, Michel; Awada, Ahmad; Conte, PierFranco; Dickin, S.; Enzmann, Harald; Hasmann, Max; Hendriks, Hans H.R.; Llombart, Antonio; Massacesi, Cristian; Von Minckwitz, Gunter; Pénault-Llorca, Frederique; Scaltriti., Maurizio; Yarden, Yosef; Zwierzina, Heinz
Informations sur la publication:Annals of oncology, 25, 4, page (773-780), mdt531
Statut de publication:Publié, 2014
Sujet CREF:Hématologie
Cancérologie
Mots-clés:Biological subtypes
Breast cancer
HER2-positive disease
Luminal disease
Triple-negative disease
MeSH keywords:Clinical Trials as Topic
Female
Humans
Molecular Targeted Therapy
Receptor, ErbB-2 -- genetics
Signal Transduction
Triple Negative Breast Neoplasms -- classification -- genetics -- pathology -- therapy
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdt531
info:pii/mdt531
info:scp/84897035109
info:pmid/24351401